GcMAF Therapy Indication
What diseases can benefit from GcMAF therapy?
Gc-MAF and/or oral Colostrum MAF macrophage activation therapy is indicated in the treatment of any diseases where there is immune disfunction or where the immune system is compromised, such as:
| Cancer | Autoimmune diseases | Epstein-Barr Virus (EBV) |
|---|---|---|
| Hepatitis B virus (HBV) | Herpes Simplex virus (HSV) | Cystitis |
| Hepatitis C virus (HCV) | Multiple sclerosis (MS) | Urinary tract infection (UTI) |
| Autism Spectrum Disorders (ASD) | Rheumatoid arthritis (RA) | Endometriosis |
| Chronic Fatigue Syndrome (CFS) | Lyme disease (Lyme borreliosis) | IgA deficiency disorder |
| Myalgic Encephalomyelitis (ME) | Mycobacteria infections | Parkinson's disease |
| Tuberculosis | Fibromyalgia | Human papillomavirus (HPV) |
| Lupus (Systemic lupus erythematosus, SLE) | HIV AIDS | Dengue fever |
| Pneumonia infection | Warts caused by viral infection | Norovirus |
| Malaria | Influenza virus (flu) | Herpes simplex virus (HSV) |
| Q fever (Coxiella burnetii) | Polycystic ovary syndrome (PCOS) | Chicken pox (varicella zoster virus) |
| Psoriasis | Respiratory tract infections | Ulcerative colitis, Crohn's disease |
| Type 1 diabetes (T1DM), insulin-dependent diabetes (IDDM) | Type 1.5 diabetes, Latent autoimmune diabetes of adults (LADA) |
